ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,991Medicare Part D Prescriptions Filled, Including Refills

Rank: 218 out of 3001

$769K Total Retail Price of All Prescriptions

Rank: 227 out of 3001

660 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,897 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 523 460 1 1
LISINOPRIL 393 381 2 2
LEVOTHYROXINE SODIUM 391 359 3 3
OMEPRAZOLE 347 279 4 4
FUROSEMIDE 294 246 5 6
HYDROCODONE-ACETAMINOPHEN 266 152 S3 6 7
AMLODIPINE BESYLATE 255 251 7 5
SERTRALINE HCL 250 219 8 20
METFORMIN HCL 233 198 9 9
WARFARIN SODIUM 220 150 10 12
CITALOPRAM HBR 218 179 11 16
CARVEDILOL 203 156 12 25
SPIRONOLACTONE 189 166 13 75
TRAMADOL HCL 181 119 14 17
OXYCODONE-ACETAMINOPHEN 170 126 S2 15 32
AZITHROMYCIN 164 127 16 36
ATENOLOL 158 121 17 18
GABAPENTIN 155 136 18 14
POTASSIUM CHLORIDE 146 120 19 15
CRESTOR 146 125 19 33
MELOXICAM 142 115 21 34
FAMOTIDINE 139 136 22 68
HYDROCHLOROTHIAZIDE 138 135 23 10
NAMENDA 114 114 24 40
LOSARTAN-HYDROCHLOROTHIAZIDE 114 114 24 49
ZOLPIDEM TARTRATE 111 57 26 24
GLYBURIDE 110 105 R 27 62
TAMSULOSIN HCL 110 94 27 29
CLOPIDOGREL 107 87 29 28
BUMETANIDE 104 98 30 151
METOPROLOL SUCCINATE 102 100 31 19
NEXIUM 101 80 32 23
SPIRIVA 100 76 33 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 79 34 77
CARBIDOPA-LEVODOPA 94 86 35 97
LORAZEPAM 93 72 36 96
IPRATROPIUM-ALBUTEROL 93 93 36 119
ALLOPURINOL 92 90 38 35
DONEPEZIL HCL 91 91 39 27
OLANZAPINE 90 90 40 106
FENTANYL 89 83 S2 41 76
METOPROLOL TARTRATE 88 85 42 8
ALENDRONATE SODIUM 86 73 43 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 80 44 22
LOSARTAN POTASSIUM 85 79 44 21
NITROFURANTOIN MONO-MACRO 82 72 46 158
DIGOXIN 82 80 46 65
PROAIR HFA 79 64 48 30
CEFUROXIME 78 69 49 178
GLIMEPIRIDE 75 62 50 31
EXELON 74 74 51 108
OXYBUTYNIN CHLORIDE 72 64 52 120
PLAVIX 71 58 53 46
CEPHALEXIN 69 53 54 86
TERAZOSIN HCL 67 62 55 135
CIPROFLOXACIN HCL 65 58 56 56
PREDNISONE 65 61 56 39
ISOSORBIDE MONONITRATE 62 55 58 355
ESCITALOPRAM OXALATE 61 52 59 82
MIRTAZAPINE 60 52 60 44
OXYBUTYNIN CHLORIDE ER 59 45 61 79
TRAZODONE HCL 58 35 62 37
GEMFIBROZIL 57 38 63 117
KLOR-CON M20 55 54 64 52
DILTIAZEM 24HR CD 55 55 64 124
ROPINIROLE HCL 55 36 64 88
NOVOLOG 54 27 67 94
METOCLOPRAMIDE HCL 53 46 68 139
ADVAIR DISKUS 52 41 69 58
ATORVASTATIN CALCIUM 52 49 69 11
ZETIA 51 51 71 69
PROPRANOLOL HCL 51 42 71 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.